arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

Lifevantage Corp

LFVN
$6.70 ▲ +0.14 (+2.13%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
64 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
76
Health
Good
Bullish
auto_awesome

Analytical Summary

Lifevantage Corp shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $84.6M
Dividend Yield 0.67%
Revenue Growth -25.2%
Op. Margin 3.8%
ROIC 4.1%
FCF / Share $0.32
Trailing P/E 60.9x
Price / Book 2.5x
FCF Yield 4.7%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

64-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$43.72M
↓ -25.2%
Net Income Profit after all expenses
$2.15M
↑ +18.0%
Operating Margin Operating profit as % of sales
3.8%
↑ +285.7% 44th
FCF / Share Free cash flow per share
$0.32
↑ +133.3%
Long-Term Debt Long-term obligations
$0.00
↓ -100.0%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
44
Returns
92
Financial Health
100
Cash Quality
69

Dividend History

Dividend / share · sourced from SEC filings
$0.17 Latest / share
-69.7% YoY
+76.5% 4-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 16 years · 64 quarters